|Articles|September 16, 2021
Pharmacy Clinical Pearl of the Day: Multiple Sclerosis
Author(s)Saro Arakelians, PharmD
In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers, causing deterioration of the nerves.
Advertisement
Clinical Pearl of the Day: Multiple Sclerosis
Multiple sclerosis (MS) is a disease of the brain and spinal cord.
Explanation:
- In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers, causing deterioration of the nerves.
- Symptoms of MS include numbness, weakness, tremor, lack of coordination, blurry vision, double vision, slurred speech, fatigues, dizziness, tingling, and problems with bowel and bladder function.
- Diagnosis could include blood test, spinal tap, MRI, and an evoked potential test.
- Treatment options may include Interferon beta, Copaxone, Gilenya, Tecfidera, Vumerity, Aubagio, Mayzent, Mavenclad, Ocrevus, Tysarbi, Lemtrada, and physical therapy.
References
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
3
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
4
FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab
5